Decipher
the gut
The gut is a black box where products are being transformed. At Cryptobiotix, we decipher this black box in the lab. We elucidate how ingested actives are affected by digestion and interact with the gut microbiome and host, impacting overall well-being. With innovative technologies and a dedicated team, we keep pushing the boundaries of preclinical research in the field.
Preclinical data
you can trust
Our ex vivo SIFR® technology pipeline bridges the gap between preclinical data and clinical outcomes, by delivering validated, predictive insights into the mechanism of action of your products. At Cryptobiotix, we help you generate the kind of data that turns scientific questions into confident, informed decisions.
Key benefits
Whether your next step involves securing IP, building a regulatory dossier or preparing for clinical trials, we provide the insights you need to proceed with clarity.
Secure IP with robust, mechanistic evidence
Support regulatory submissions
with targeted mode-of-action data
De-risk clinical trials by modelling
inter-individual gut responses early in development
Gastrointestinal & gut microbiome
research services
We design every project around your research questions,
using our ex vivo SIFR® technology pipeline to deliver:
Digestion, gut microbiome and host simulation
Simulate the human GI tract and the microbiome under biorelevant physiological conditions
Mechanistic insights
Uncover mode-of-action, dose–response and inter-individual variability
Actionable reporting
Comprehensive and impactful report to facilitate your next steps
Our modular pipeline lets you navigate full-GI digestion, colonic fermentation and host–microbiome interactions. Enjoy high-throughput results with the highest standards of validation.
NEW – Biobanking
Add a dimension to your preclinical studies, understanding better your donors and their microbiota. You define the cohort that is the most relevant for your business and you get results faster.
Publications
Explore our research findings and insights into the gut microbiome. We’re committed to sharing our discoveries with the scientific community to advance knowledge in this field.
